SLC5A2 and heart failure: Finally, Clemmer et al. and Li W et al. have investigated the impact of SGLT-2 inhibitors on mortality and heart failure hospitalization, respectively, and reported improvement in both outcomes, but because they are retrospective cohort studies, they are subject to selection bias, missing data, and confounding factors.